Molecular subtypes and individualized treatment of breast cancer.
- Author:
Bing-he XU
1
;
Ping ZHANG
Author Information
1. xubinghe@medmail.com.cn
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal;
therapeutic use;
Antibodies, Monoclonal, Humanized;
therapeutic use;
Antineoplastic Agents;
therapeutic use;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Breast Neoplasms;
classification;
metabolism;
pathology;
surgery;
therapy;
Carcinoma;
classification;
metabolism;
pathology;
surgery;
therapy;
Cetuximab;
Chemotherapy, Adjuvant;
Cyclophosphamide;
therapeutic use;
Female;
Fluorouracil;
therapeutic use;
Humans;
Lymphatic Metastasis;
Methotrexate;
therapeutic use;
Neoplasm Staging;
Receptor, ErbB-2;
metabolism;
Receptors, Estrogen;
metabolism;
Receptors, Progesterone;
metabolism;
Trastuzumab
- From:
Chinese Journal of Oncology
2010;32(9):641-644
- CountryChina
- Language:Chinese
